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bstract
Oxidative modification of low-density lipoprotein (LDL) represents an important factor in atherogenesis. In the present study, we have
nvestigated the antioxidant capability of diphenyl diselenide (PhSe)2, a simple organoseleno compound, against copper (Cu2+) and peroxyl
adical-induced human LDL oxidation in vitro. In initial studies using human serum, (PhSe)2 caused a dose-dependent inhibition of Cu2+-
nduced lipid peroxidation, which was correlated to thiol consumption. (PhSe)2 increased lipid peroxidation lag phase and decreased lipid
eroxidation rate in isolated human LDL, evaluated by measuring both conjugated diene (CD) and thiobarbituric acid reactive substances
TBARS) levels. Consistent with these observations, (PhSe)2 showed a marked inhibitory effect on 2,2-azobis(2-amidinopropane dihydrochlo-
ide) (AAPH)-induced oxidation of LDL or parinaric acid (PnA) incorporated into LDL. (PhSe)2 also displayed a dose-dependent protective
ffect against Cu2+-induced lipid peroxidation in rat aortic slices. Interestingly, besides the antioxidant effects of (PhSe)2 toward the lipid
oieties of LDL, which was related to its thiol-peroxidase activity, protein moieties from human isolated LDL were also protected against
u2+-induced oxidation. The results presented herein are the first to show that (i) (PhSe)2 inhibits lipid peroxidation in human isolated LDLn vitro, (ii) this phenomenon is related to its thiol-peroxidase activity, and (iii) this chalcogen also prevents the oxidation of protein moieties
f human LDL. Taken together, such data render (PhSe)2 a promising molecule for pharmacological studies with respect to the atherogenic
rocess.
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. Introduction
Atherosclerosis remains the most common cause of death
n industrialized countries. This affects the vascular wall and
eads to coronary artery diseases and cerebrovascular acci-
ents (stroke) [1]. There is increasing evidence that oxidativePlease cite this article in press as: Bem AF, et al., Diphenyl diselenide
oxidation in vitro, Atherosclerosis (2008), doi:10.1016/j.atherosclerosis.
odifications of low-density lipoprotein (LDL) play a pivotal
ole in the development of atherosclerosis. Moreover, ele-
ated levels of oxidized LDL have been positively correlated
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o the severity of acute coronary events and have been con-
idered a biochemical marker for coronary heart disease [2].
Although the molecular bases related to the triggering pro-
ess of LDL oxidation remain unclear, the major mechanisms
urrently explored are metal ions dyshomeostasis, changes in
ipoxygenase- and myeloperoxidase-related pathways, reac-
ive oxygen and nitrogen species generation, and alterations
n the thiol status [3]., a simple glutathione peroxidase mimetic, inhibits human LDL
2008.02.030
Since LDL oxidation plays a key role in the pathogenesis
f atherosclerosis, antioxidants that can inhibit this oxidative
rocess might be useful in preventing atherosclerosis-related
athological conditions, such as coronary artery diseases and
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troke [4]. In this regard, it has been evidenced that antiox-
dant capability of LDL can be easily increased by dietary
ntioxidant supplementation. In fact, many endogenous and
xogenous compounds have been reported to display benefi-
ial effects against LDL oxidation [5].
Selenium (Se) is an essential nutrient associated with the
unction of major metabolic pathways in the cell, where it is
ncorporated as selenocysteine at the active site of a wide
ange of proteins [6]. Selenium intake is inversely corre-
ated to the incidence of atherosclerosis and coronary heart
isease [7]. In endothelial cells, selenium can protect from
xidative damage by altering the expression of selenoproteins
hich have antioxidant function, including cytoplasmic glu-
athione peroxidase (cyGPX), phospholipid hydroperoxide
lutathione peroxidase (PHGPx) and thioredoxin reductase
TR) [8].
The interest in organoselenium chemistry and biochem-
stry has increased in the last three decades mainly due
o the fact that several organoselenium compounds pos-
ess antioxidant activity [9], which is interplayed with its
lutathione-peroxidase-like activity [10,11]. The first exam-
le of such a compound was ebselen [12,13], and this
ompound has been extensively studied in reason of its
ntioxidants and anti-inflammatory properties [14,15]. Con-
idering the pharmacological properties of ebselen, we have
een studying the pharmacological properties of another
rganoselenium compound, diphenyl diselenide (PhSe)2,
hich also exhibits thiol-peroxidase-like activity which is
bout two times that of ebselen [10,16].
This organoselenium caused minimal toxicity when
dministrated acutely to mice and rats [17] and after a long
erm exposure to rabbits [18,19] and has been reported to
resent lower toxicity than ebselen [11]. Recently, studies
rom our laboratory have demonstrated that (PhSe)2 caused
significant reduction in blood glucose and glycated protein
evels in diabetic rats [20]. Moreover, the in vitro and in vivo
ntioxidant potential of (PhSe)2 was already demonstrated in
everal tissues and models, including brain, liver and platelets
11,21].
Given the earlier observations, the present study was car-
ied out to evaluate the potential beneficial effects of (PhSe)2
n protecting in vitro oxidation using different methodologi-
al approaches: human serum, human isolated LDL, and rat
ortic slices (rich in endothelial cells), which are the main
lements involved in the early atherosclerosis development
n vivo. The thiol-peroxidase capability of (PhSe)2 was also
valuated in an attempt to delve into molecular mechanisms
elated to the aforementioned antioxidant effects.
. Materials and methodsPlease cite this article in press as: Bem AF, et al., Diphenyl diselenide
oxidation in vitro, Atherosclerosis (2008), doi:10.1016/j.atherosclerosis.
.1. Materials
Diphenyl diselenide (PhSe)2 was synthesized according
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MR and 13C NMR spectra showed that the obtained com-
ound had analytical and spectroscopic data in full agreement
ith its assigned structure. The chemical purity of (PhSe)2
99.9%) was determined by GC/HPLC. (PhSe)2 was solubi-
ized in ethanol PA and a 10-mM stock solution was stored at
◦C for less than 2 weeks. Immediately before use, (PhSe)2
as diluted in ethanol PA at the required concentrations for
he different assays. All other chemicals were of analytical
rade and obtained from standard commercial suppliers.
.2. Serum oxidation
The study was approved by our Ethic Committee at
niversidade Federal de Santa Maria. Blood samples were
ollected from healthy and normolipidemic volunteers after
12-h overnight fasting period. Samples were left to clot
n the dark at room temperature for 30 min and then cen-
rifuged at 1500 × g for 15 min. The serum was removed and
mmediately used in the oxidation assays and oxidations were
erformed in serum rather than in plasma to avoid poten-
ial interferences of substances such as EDTA, heparin, or
itrate. Briefly, serum samples were diluted 1:4 in 10 mM
otassium phosphate buffer, pH 7.4 and incubated at 37 ◦C
ith CuSO4 (100M) and/or (PhSe)2 (0–200M). The total
olume was 9 mL. At different time points, aliquots (200L)
ere removed for evaluating thiobarbituric acid reactive sub-
tances (TBARS) levels and consumption of the total thiol
roups (–SH). Serum TBARS levels and thiol groups were
etermined based on Ohkawa et al. [23] and Ellman [24],
espectively.
.3. Thiol-peroxidase activity of (PhSe)2 and
pectroscopy studies
The thiol-peroxidase activity of (PhSe)2 was measured
ccording to a method previously described by Wilson et al.
10]. (PhSe)2 (50M) was incubated at 37 ◦C in a medium
ontaining 50 mM potassium phosphate buffer, pH 7.0, 1 mM
thylene diamine tetraacetic acid (EDTA), 1 mM reduced
lutathione (GSH), 1 U of GR and 0.25 mM NADPH (final
olume of reaction = 1 mL). The reaction was initiated by
ddition of 0.5mol of hydrogen peroxide. The activity was
ollowed by the decrease of NADPH absorption at 340 nm.
ppropriate controls were carried out without (PhSe)2 and
ere subtracted.
In order to evaluate the potential chemical interaction
etween (PhSe)2, GSH and H2O2, (PhSe)2 (20M) was
ncubated with GSH (200M) in 10 mM potassium phos-
hate buffer (pH 7.4). The reaction was performed at 37 ◦C
n a quartz cuvette and monitored spectrophotometrically
250–400 nm) using a PerkinElmer Lambda 6 spectropho-
ometer. In additional experiments, H O (200M) was, a simple glutathione peroxidase mimetic, inhibits human LDL
2008.02.030
dded 1 min after the reaction of (PhSe)2 with GSH. The reac-
ion mixture had 2 mL. Temperature was maintained using a
irculating water bath. Readings were done against a refer-
nce cuvette containing phosphate buffer.
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.4. LDL isolation
LDL was isolated from fresh human plasma by discon-
inuous density-gradient ultracentrifugation as described by
ilva et al. [25], with slight modifications. Plasma of non-
asted healthy normolipidemic donors collected with EDTA
1 mg/mL) was pooled and sucrose (final concentration,
.5%) was added to prevent LDL aggregation. Five milliliters
f EDTA–plasma adjusted to a density of 1.22 g/mL with
olid KBr (0.326 g/mL) was layered on the bottom of a cen-
rifuge tube. Then 5 mL EDTA-containing sodium chloride
olution (density 1.006 g/mL) was overlaid on top of the
lasma. Ultracentrifugation was run at 65,000 rpm for 2 h
t 4 ◦C, in a Hitachi ultracentrifuge. LDL particles were col-
ected by aspiration of the yellow band, which is located in
he middle of sodium chloride solution just above the plasma
ain fractions. Then, 4 mL of LDL particles was dialyzed
xhaustively overnight at 4 ◦C against 6 L of 10 mM phos-
hate buffer to remove the excess salt and the majority of
he EDTA. Protein concentration in LDL solution was deter-
ined by Lowry et al. [26]. The purity of LDL preparation
as verified by agarose gel electrophoresis. Isolated LDL
as stored at −20 ◦C not longer than 2 weeks.
.5. LDL oxidation
Incubation of LDL with copper ions initiates lipid per-
xidation and causes extensive oxidation of the LDL lipids.
u2+-mediated oxidation is frequently used to assess the sus-
eptibility of LDL to oxidation which is regarded as a possible
isk factor for atherosclerosis [27].
LDL oxidation was monitored by following the CD for-
ation and the TBARS production. LDL samples (50g
rotein/mL) were pre-incubated at 37 ◦C in a medium con-
aining 10 mM potassium phosphate buffer, pH 7.4 and
ifferent concentrations of (PhSe)2 (0–40M). After 10 min,
uSO4 (1.6, 5 or 10M) was added to the reaction medium
nd aliquots were removed at different time points for
valuating CD and TBARS production. In another set of
xperiments, (PhSe)2 (40M) was added at different time
oints (0, 45 or 90 min) in an attempt to evaluate whether
PhSe)2 could inhibit Cu2+-induced LDL oxidation once the
rocess was started.
Potential antioxidant effects of (PhSe)2 against LDL
xidation were also evaluated after the addition of an
zo initiator, 2,2-azobis(2-amidinopropane dihydrochloride)
AAPH) (1 mM), whose slow decomposition generates per-
xyl radical at a constant rate in aqueous medium and induces
he chain oxidation of human LDL by a free radical mediated
echanism.
In the studies of CD formation, the temporal change in
bsorbance at 234 nm (which refers to the CD concentration)Please cite this article in press as: Bem AF, et al., Diphenyl diselenide
oxidation in vitro, Atherosclerosis (2008), doi:10.1016/j.atherosclerosis.
s divided into three phases: a lag phase, a propagation phase,
nd a terminal phase. The lag phase was defined as the inter-
ept of the tangent of the slope of the absorbance curve in
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in. The rate of propagation was obtained from the slope
f the absorbance curve during the propagation phase, and
he terminal phase corresponds to the extensive oxidation of
ipids of LDL. Absorbance at 234 nm was normalized with
espect to the absorbance at the beginning of the oxidation
rocess.
.6. Measurement of parinaric acid (PnA) fluorescence
PnA is a polyunsaturated fatty acid that has been used suc-
essfully as a fluorescent probe to monitor the initial stages
f lipid peroxidation by peroxyl radicals from AAPH [28].
is-PnA (9,11,13,15-octadecatetraenoic acid) fluorescence
as monitored in a PerkinElmer LS 50 spectrofluorometer
rovided with a thermostated cuvette containing a magnetic
tirring device. The excitation and emission wavelengths
ere 324 and 413 nm, respectively (slit widths: 3.5 nm).
Preliminary studies were performed in order to deter-
ine the concentration of LDL and PnA that insure totally
ncorporation of the probe into LDL and a linear fluorescent
esponse with PnA concentration. The assays were performed
t 37 ◦C in 2 mL of potassium phosphate buffer (110 mM
aCl, 20 mM phosphate, pH 7.4) containing 45g of LDL
rotein and an aliquot of ethanolic solution of PnA (1.5M
nal concentration). The incorporation of the probe was car-
ied out by gentle stirring for 1 min. Increasing concentrations
f (PhSe)2 were added to the mixture and the oxidation
eaction was initiated by addition of AAPH (10 mM final
oncentration). The capacity of (PhSe)2 to protect LDL from
xidation was determined by the inhibition of probe fluores-
ence decay [28].
.7. Measurement of LDL-Trp fluorescence
The time course of tryptophan (Trp) fluorescence emis-
ion intensity is used to monitor Cu2+-induced apolipoprotein
DL oxidation. The fluorescence spectra of native LDL dis-
lay a single band centered at approximately 332 nm, which is
ssigned to the Trp residues in apo B. Loss of Trp fluorescence
s a marker for oxidations at the protein core of LDL [29].
u2+-induced LDL oxidation was performed in a similarly
ay to item described in Section 2.5, excepting that 3.3M
uSO4 and different (PhSe)2 concentrations (0–30M) were
sed. Trp fluorescence was measured at different time points
0–360 min) using a Shimatzo spectrofluorometer (excitation
t 282 nm and emission at 331 nm).
.8. Aortic slices oxidation
Adult Wistar rats were decapitated, thoracic aorta were
uickly dissected and then removed, rinsed and submerged
n a petri dish filled with ice-cold isosmotic phosphate, a simple glutathione peroxidase mimetic, inhibits human LDL
2008.02.030
uffer (NaCl 124 mM, Na2HPO4 10 mM, NaH2PO4 5 mM,
H2PO4 5 mM, glucose 10 mM, pH 7.4) and cleaned of
dherent fat and connective tissue in an ice-bath. Trans-
erse propsections (400m) were prepared using a McIlwain
 IN PRESSATH-10336; No. of Pages 9














































Fig. 1. (A) Effects of (PhSe)2 on Cu2+-induced lipid peroxidation and thiol
consumption in human serum. At different time points (indicated in the
abscissa axis) TBARS (solids line) and SH (broken lines) content were
analyzed (see Section 2). TBARS levels are expressed as nmol of mal-
ondialdehyde (MDA). Total thiol (–SH) content is expressed as percent
of control, whose basal concentration was 437 ± 25 nmol/mL. Results are
represented as mean ± standard error of mean (S.E.M.) from at least three
independent experiments. (B) The comparative spectra of (PhSe)2 and the
products of its interaction with GSH and/or H2O2. (A) (PhSe)2 (20M);
(B) GSH (200M); (C) (PhSe)2 (20M) + GSH (200M) + 1 min at 37 ◦C;
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issue chopper. Aortic slices (10 slices) were incubated in
sosmotic phosphate buffer with 20 or 40M of (PhSe)2
nd/or 10M CuSO4 for 2 h. After incubations, aorta
lices were washed with saline and homogenized in 400L
f acetic acid buffer (pH 3.5). Lipid oxidation in aorta
omogenates was measured by determining TBARS, as
escribed by Ohkawa et al. [23]. Experimental procedures
nvolving animals were approved by the local Animal Care
ommittee.
.9. Statistical analysis
Values are expressed as mean ± S.E.M. One-way analysis
f variance (ANOVA) was used for multiple comparisons,
ollowed by the Duncan’s multiple range test when the F-
alue was significant. Only significant F-values are given
n the text. Linear regression analysis was also used to test
ose-dependent effects. All analyses were performed using
he Statistical Package for the Social Sciences (SPSS) soft-
are in a PC-compatible computer. A value of p < 0.05 was
onsidered to be significant.
. Results
.1. Effects of (PhSe)2 on serum oxidation
The protective effects of (PhSe)2 against Cu2+-induced
BARS generation and thiol consumption in blood serum
re depicted in Fig. 1A. Cu2+ (100M) caused a time-
ependent increase of serum TBARS levels (Fig. 1A, right,
axis) and a time-dependent decrease of total thiol groups
Fig. 1A, left, Y axis). Interestingly, even though (PhSe)2
isplayed a concentration-dependent inhibitory effect toward
u2+-induced TBARS generation (F(4,10) = 21.18; p < 0.001;
= −0.877), there was a stimulation of thiol groups con-
umption by (PhSe)2.
.2. Spectroscopy studies
In order to delve into molecular mechanisms involved
ith the beneficial role of (PhSe)2 against LDL lipid per-
xidation, in vitro experiments of light/UV spectroscopy
oncerning the chemical interaction between (PhSe)2, GSH
nd H2O2 were investigated spectrophotometrically. The
haracteristic spectra of 20M (PhSe)2 (line A, Fig. 1B)
nd of 200M GSH (line B, Fig. 1B) was changed after
heir reaction (line C, Fig. 1B), probably due to the forma-
ion of phenyl selenol intermediate (PhSe−). Interestingly,
fter the addition of H2O2 (200M), the strong and broad
bsorption peak at 270 nm of such intermediate was abol-
shed, indicating its chemical interaction with H2O2 (Fig. 1B,Please cite this article in press as: Bem AF, et al., Diphenyl diselenide
oxidation in vitro, Atherosclerosis (2008), doi:10.1016/j.atherosclerosis.
pectrogram D). Consistent with this observation, (PhSe)2
isplayed a concentration-dependent glutathione peroxidase-
ike activity (Fig. 1B, inset), which was indirectly measured




c7 ◦C. Spectra of 20M (PhSe)2 or 200M GSH were not modified by
ddition of 200M H2O2. For details, see Section 2. The inset graph shows
lutathione peroxidase activity of (PhSe)2.
SH reductase and hydrogen peroxide. The peroxidase-like
ctivity of (PhSe)2 was approximately twice when compared
o that of ebselen (data not show), these results are in agree-
ent with the previous study of Wilson et al. [10], where
hey showed that (PhSe)2 is about 1.6 times more effective
s GPx-mimetic than ebselen. Moreover, (PhSe)2 catalyti-
ally increased GSH oxidation in the presence of H2O2 in, a simple glutathione peroxidase mimetic, inhibits human LDL
2008.02.030
concentration-dependent manner (data not show). Taken
ogether, these data indicate that the chemical interaction
etween (PhSe)2 and GSH produces an intermediate that is
apable of interacting with peroxides. This process allows for
 IN PRESSATH-10336; No. of Pages 9















































Fig. 2. (A) Effects of (PhSe)2 on AAPH-induced conjugated dienes for-
mation in human LDL. At different time points, conjugated dienes were
analyzed. LDL samples (50g protein/mL) were incubated at 37 ◦C with
1.0 mM AAPH in the absence (control) or presence (3–50M) of (PhSe)2
(broken lines represent control conditions without Cu2+ addition). Con-
jugated dienes are expressed as absorbance at 234 nm. Inset shows the
significant correlation between oxidation rate and (PhSe)2 concentrations
(F(7,16) = 83.21; p < 0.001; β = −0.944). (B) Effect of (PhSe)2 on AAPH-
induced oxidation of PnA incorporated into LDL. LDL samples (45g
protein) were incubated at 37 ◦C with 1.5M PnA for 1 min under gen-
tle stirring. AAPH (1.0 mM) and (PhSe)2 (0, 2, 3, or 4M; 3 min after
AAPH addition) were added to the reaction medium. Inset shows a typical
control assay of PnA oxidation, incorporated into LDL, initiated by AAPH.
The fluorescence intensity was recorded up to 30 min and shows the initial
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he detoxification of peroxides at the expenses of sulfhydryl
roups from GSH.
.3. Effects of (PhSe)2 on the LDL oxidation
.3.1. (PhSe)2 effects on AAPH-mediated lipid LDL
xidation
The effects of (PhSe)2 on AAPH-mediated lipid
DL oxidation is depicted in Fig. 2A. AAPH caused
significant increase of CD formation within time
Fig. 2A). (PhSe)2 (3–50M) showed a marked inhibitory
ffect on AAPH-induced lipid LDL oxidation in a
oncentration-dependent manner. In fact, a significant neg-
tive correlation (F(7,16) = 83.21; p < 0.001; β = −0.944) was
bserved for (PhSe)2 concentrations and CD levels (inset
ig. 2A).
.3.2. (PhSe)2 effects on PnA fluorescence
Fig. 2B shows that low concentrations of (PhSe)2
2–4M) caused a concentration-dependent inhibition
F(3,8) = 684.27; p < 0.001; β = 0.215) of the fluorescence
ntensity decay of PnA in the presence of AAPH when com-
ared to the control condition (absence of (PhSe)2). The inset
f Fig. 2B indicates a typical control assay where the decrease
f the fluorescence of PnA following the addition of AAPH
eflects its oxidative degradation.
.3.3. (PhSe)2 effects on Cu2+-induced LDL oxidation
The effects of (PhSe)2 on Cu2+-induced lipid oxidation
n isolated LDL are depicted in Fig. 3. (PhSe)2 inhib-
ted Cu2+-induced generation of both CDs (Fig. 3, left)
nd TBARS (Fig. 3, right) in a concentration-dependent
anner. Cu2+ displayed concentration-dependent oxida-
ive effects toward lipids, evaluated by measuring CDs
Fig. 3). LDL oxidation showed an expected oxidation
attern of an initial lag phase followed by a propa-
ation phase and a decomposition phase (Fig. 3, left),
s originally described by Esterbauer et al. [4]. Interest-
ngly, (PhSe)2 caused concentration-dependent increases
n lag phase and decreases in the oxidation rate, evi-
enced by changes in the propagation phase slope
Cu2+ 1.6M: F(3,8) = 104.05; p < 0.001; β = −0.910; Cu2+
M: F(3,8) = 650.72; p < 0.001; β = −0.956; Cu2+ 10M:
(3,8) = 41.46; p < 0.001; β = −0.932).
In another set of experiments, (PhSe)2 (40M) was added
t different time points (0, 45 or 90 min) in an attempt to
valuate whether (PhSe)2 could inhibit Cu2+-induced lipid
DL oxidation once the process was started. Fig. 4A shows a
ignificant inhibitory effect of (PhSe)2 toward Cu2+-induced
ipid LDL oxidation when present at the beginning of thePlease cite this article in press as: Bem AF, et al., Diphenyl diselenide
oxidation in vitro, Atherosclerosis (2008), doi:10.1016/j.atherosclerosis.
xidation process. Interestingly, (PhSe)2 inhibited Cu2+-
nduced lipid LDL oxidation when added to the reaction





iesults are derived from a single representative experiment. Experiments
ere repeated at least three times, showing similar results.
.4. Effects of (PhSe)2 on the LDL-Trp fluorescence
mission
Fig. 4B shows that protein moieties of LDL are oxi-, a simple glutathione peroxidase mimetic, inhibits human LDL
2008.02.030
ized within time in the presence of CuSO4 (3.3M). This
henomenon was prevented by (PhSe)2 in a concentration-
ependent manner (F(3,8) = 104.05; p < 0.001; β = 0.954). It
s noteworthy that Cu2+-induced apolipoprotein LDL oxida-
Please cite this article in press as: Bem AF, et al., Diphenyl diselenide, a simple glutathione peroxidase mimetic, inhibits human LDL
oxidation in vitro, Atherosclerosis (2008), doi:10.1016/j.atherosclerosis.2008.02.030
ARTICLE IN PRESSATH-10336; No. of Pages 9
6 A.F. Bem et al. / Atherosclerosis xxx (2008) xxx–xxx
Fig. 3. Effects of (PhSe)2 on Cu2+-induced lipid peroxidation in human LDL. At different time points (indicated in the abscissa axis), conjugated dienes (left)
and TBARS (right) were analyzed. LDL samples (50g protein/mL) were incubated in the presence of 1.6M (A), 5.0M (B) and 10M (C) CuSO4 and in
the absence (control) or presence (1–40M) of (PhSe)2 (broken lines represent control conditions without Cu2+ addition). TBARS levels are expressed as nmol
of malondialdehyde (MDA). Conjugated dienes are expressed as absorbance at 234 nm. Results are represented as mean ± standard error of mean (S.E.M.)
from at least three independent experiments.
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Fig. 4. (A) Effects of (PhSe)2 on Cu2+-induced conjugated dienes formation
in previously oxidized human LDL. LDL samples (50g protein/mL) were
incubated at 37 ◦C in the presence of 1.6M CuSO4 and in the absence (con-
trol) or presence (40M) of (PhSe)2, which was added at 0, 45 or 90 min
after CuSO4 addition. At different time points (indicated in the abscissa axis),
conjugated dienes were analyzed. Results are expressed as absorbance at
234 nm. Results are derived from a single representative experiment. Exper-
iments were repeated at least three times, showing similar results. (B) Effects
of (PhSe)2 on Cu2+-induced loss of tryptophan fluorescence in human LDL.
LDL samples (50g protein/mL) were incubated at 37 ◦C in the presence of
3.3M CuSO4 and different (PhSe)2 concentrations (0–30M). Tryptophan
fluorescence (excitation at 282 nm and emission at 331 nm) was measured
at different time points (0–360 min) (broken lines represent control con-









Fig. 5. Effect of (PhSe)2 on Cu2+-induced lipoperoxidation in rat aortic


























tmission intensity measured before Cu2+ addition. Results are represented
s mean ± standard error of mean (S.E.M.) from at least three independent
xperiments.
ion was almost completely abolished in the presence of 20
nd 30M of (PhSe)2.
.5. Aortic slices oxidationPlease cite this article in press as: Bem AF, et al., Diphenyl diselenide
oxidation in vitro, Atherosclerosis (2008), doi:10.1016/j.atherosclerosis.
The effects of (PhSe)2 on Cu2+-induced lipid peroxidation
n rat aortic slices are depicted in Fig. 5. One-way ANOVA




trotein and presented as mean ± standard error of mean (S.E.M.) of 3–4
ndependent experiments. Controls are represented by an open bar. *p < 0.05;
*p < 0.01 (One-way ANOVA followed by the Duncan’s multiple range test).
ion in rat aortic slices. Co-incubation of aortic rats slices with
PhSe)2 for 2 h was associated with a reduction in lipid per-
xidation induced by copper ions (F(2,13) = 8,67; p < 0.01).
PhSe)2 was effective in decreasing Cu2+-induced TBARS
ormation in a concentration-dependent manner (Fig. 5;
= −0.740, p < 0.01).
. Discussion
Oxidative damage to lipoproteins, in particular LDL, is
nown to play a role in a number of diseases associated with
geing and is in agreement with the oxidative stress theory
f ageing [30]. Oxidized LDL is involved in the develop-
ent of atherosclerosis through the formation of foam cells
31] and autoantibodies against oxidized LDL [32]. Since
DL oxidative damage is involved in the development of
therosclerosis, several recent studies have sought for the
otential beneficial effects of antioxidant molecules against
DL oxidation [5,33]. Of particular importance, epidemi-
logical studies have pointed to red wine polyphenols as
romising molecules that could prevent the development of
everal coronary syndromes by inhibiting the atherogenic
rocess [34].
There is considerable evidence suggesting that an ele-
ated plasma copper concentration is associated with existing
therosclerosis and represents a factor of risk for disease in
he future [35]. Catalytically active copper ion has been found, a simple glutathione peroxidase mimetic, inhibits human LDL
2008.02.030
n gruel taken from human advanced atherosclerotic lesions,
ndicating that the interior of human advanced atherosclerotic
esions is a highly pro-oxidant environment. Consequently,
he use of copper ions to promote peroxidation of LDL under
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n vitro conditions can be considered a valid model for study-
ng events occurring in atherosclerotic arterial wall [36]. In
ddition, AAPH-generated hydroxyl radical has been also
eported as a good alternative for mimicking oxidative insults
hat occur toward lipid and protein moieties of LDL during
he atherogenic process [37].
Even though several studies have reported the benefi-
ial effects of organoseleno compounds against pathological
onditions associated to oxidative stress (inflammation, gas-
ric mucosal damage, neurotoxicity, and hepatotoxicity [11]),
here are no reports regarding beneficial effects of (PhSe)2
gainst human LDL oxidative damage. In fact, it appears
hat ebselen is the only organoseleno compound that has
eceived considerable interest during the last decades [14,15].
n the present study, the choice for studding (PhSe)2 as a
otential beneficial molecule against human LDL oxidation
as based on previous studies from our group, which has
hown that (PhSe)2 displays a higher capability of ebselen
n detoxifying peroxides at expenses of sulfhydryl molecules
21].
Here, we observed that (PhSe)2, an organoseleno com-
ound with glutathione peroxidase-like activity, displayed
eneficial effects against oxidation induced by copper ions
r AAPH, a hydroxyl radical generator, on human serum and
solated LDL and rat aortic slices. (PhSe)2 increased the oxi-
ation lag phase and decreased the oxidation rate in isolated
uman LDL and these phenomena were evidenced by using
ifferent methodological approaches, including the TBARS
easurement, CDs generation and incorporation of PnA into
he lipoproteins.
On the other hand, (PhSe)2 showed an antioxidant effect
n Cu2+-induced oxidation of human serum and this effect
as in a concentration-dependent manner. Moreover, this
ffect showed a temporal correlation with the sulfhydryl
roups consumption: the increase of TBARS levels started
ust when stopped the decrease of SH levels (120 min).
his phenomenon suggests the need for available reduced
ulfhydryl groups for the maintenance of the beneficial effect
f (PhSe)2 against Cu2+-induced lipid peroxidation, rein-
orcing the idea of the involvement of thiol-peroxidase-like
ctivity on the antioxidant effects of (PhSe)2.
This idea is reinforced by the observed beneficial effects of
PhSe)2 against the oxidation of endogenous and exogenous
incorporated PnA) LDL lipids. Inline with this, spec-
roscopic studies showed the direct chemical interaction
etween (PhSe)2 and GSH, resulting in the formation of a
hemical intermediary whose stability is affected by the pres-
nce of hydrogen peroxide. Furthermore, we demonstrated
concentration-dependent antioxidant effect of (PhSe)2 on
u2+-oxidized rat aortic slices, indicating its antiatherogenic
otential. Therefore, (PhSe)2 behaves as a potent antioxi-
ant in different models intimately related to the atherogenicPlease cite this article in press as: Bem AF, et al., Diphenyl diselenide
oxidation in vitro, Atherosclerosis (2008), doi:10.1016/j.atherosclerosis.
rocess.
An interesting effect of this study was that (PhSe)2 dis-
layed significant beneficial effects in the different phases
f Cu2+-induced LDL oxidation. In fact, when added to the PRESS
is xxx (2008) xxx–xxx
eaction medium at time zero (Fig. 3A), (PhSe)2 signifi-
antly prevented LDL oxidation. Moreover, when added to
he reaction medium at 45 or 90 min (partially oxidized LDL),
PhSe)2 was capable of stopping CDs formation. Mecha-
istically, these results are of interest because they indicate
hat the thiol-peroxidase activity of (PhSe)2 is enough impor-
ant to prevent the generation of secondary products of lipid
eroxidation, such as CDs.
Another significant (and maybe the most important) result
rom our study was the capability of (PhSe)2 to prevent Cu2+-
nduced loss of Trp fluorescence in human LDL. In this
egard, it has been reported that the fluorescence spectrum of
ative LDL displays a single band centered at approximately
32 nm, which is assigned to the Trp residues in apo B and
oss of Trp fluorescence is a marker for oxidations at the pro-
ein core of LDL [29]. The protective effect of (PhSe)2 against
u2+-induced loss of Trp fluorescence indicates that, besides
t’s beneficial effects against oxidation of lipid moieties of
DL, this chalcogen also prevents the oxidation of protein
oieties of human LDL, pointing to an additional mecha-
ism that could contribute to the inhibition of the atherogenic
rocess.
The results of the present study are the first to show that (i)
PhSe)2 inhibits lipid peroxidation in human isolated LDL in
itro, (ii) this phenomenon is related to its thiol-peroxidase
ctivity, and (iii) this chalcogen also prevents the oxidation
f protein moieties of human LDL. Taken together, such data
ender (PhSe)2 a promising molecule for pharmacological
tudies with respect to the atherogenic process.
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